Synapse - Ingo Mellinghoff

Search Within

Ingo K Mellinghoff

Results (271)

Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGhT): A phase II platform trial using bayesian adaptive randomization

Meeting Abstract

Arrillaga-Romany, I.; Trippa, L.; Fell, G.; Lee, E. Q.; Rahman, R.; Touat, M.; McCluskey, C.; Bruno, J.; Gaffey, S.; Drappatz, J.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

18F-fluoroglutamine PET as a promising prognostic tool in IDH mutant glioma

Meeting Abstract

Krebs, S.; Graham, M. S.; Grkovski, M.; Mauguen, A.; Goel, R.; Thakur, S. B.; Schaff, L. R.; Mellinghoff, I. K.; Young, R. J.; Kaley, T.; more...
European Journal of Nuclear Medicine and Molecular Imaging (2021)

Fulltext@MSK | Save

Clinical and molecular features of a prospectively-sequenced cohort of glioblastoma patients with inherited disorders in mismatch repair

Meeting Abstract

Elmore, K.; Stadler, Z.; Piotrowski, A.; Schaff, L.; Gavrilovic, I.; Stone, J.; Dunkel, I.; Tabar, V.; Mellinghoff, I.; Bale, T.; more...
Neurology (2021)

Fulltext@MSK | Save

GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma

Meeting Abstract

Wen, P. Y.; Mellinghoff, I. K.; Buxton, M. B.; Cavenee, W. K.; Colman, H.; De Groot, J. F.; Ellingson, B. M.; Gordon, G. B.; Khasraw, M.; Lassman, A. B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

The 1994 National Cancer Institute's strategy to fund multi-institutional, multidisciplinary consortia to design and conduct early phase clinical trials in patients with high grade gliomas

Meeting Abstract

Grossman, S. A.; Nabors, L. B.; Fisher, J. D.; Wen, P. Y.; Timmer, W. C.; Barker, F. G.; Peereboom, D. M.; Ellingson, B. M.; Supko, J. G.; Rudek, M. A.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Impact of mutant IDH (mIDH) inhibition on DNA hydroxymethylation, tumor cell function, and tumor immune microenvironment (TIME) in resected mIDH1 lower-grade glioma (LGG)

Meeting Abstract

Lu, M.; Cloughesy, T. F.; Wen, P. Y.; Tassinari, A.; Choe, S.; Zhu, D.; Hassan, I.; Steelman, L.; Pandya, S. S.; Wu, B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Prognostic value of [(18)F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies

Journal Article

Krebs, S.; Mauguen, A.; Yildirim, O.; Hatzoglou, V.; Francis, J. H.; Schaff, L. R.; Mellinghoff, I. K.; Schöder, H.; Grommes, C.
European Journal of Nuclear Medicine and Molecular Imaging (2021)

Fulltext@MSK | Save

Vorasidenib, a dual inhibitor of mutant IDH1/2, in recurrent or progressive glioma; Results of a first-in-human phase I trial

Journal Article

Mellinghoff, I. K.; Penas-Prado, M.; Peters, K. B.; Burris, H. A. 3rd; Maher, E. A.; Janku, F.; Cote, G. M.; de la Fuente, M. I.; Clarke, J. L.; Ellingson, B. M.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save

Next-generation sequencing of cerebrospinal fluid for clinical molecular diagnostics in adolescent and young adult (AYA) brain tumor patients

Meeting Abstract

Miller, A.; Szalontay, L.; Bouvier, N.; Ahmed, H.; Hill, K.; Rafailov, J.; Lee, A.; Rodriguez-Sanchez, I.; Yildirim, O.; Patel, A.; more...
Neuro-Oncology (2021)

Fulltext@MSK | Save

Clinical experience of cerebrospinal fluid-based liquid biopsy demonstrates superiority of cell-free DNA over cell pellet genomic DNA for molecular profiling

Journal Article

Bale, T. A.; Yang, S. R.; Solomon, J. P.; Nafa, K.; Middha, S.; Casanova, J.; Sadowska, J.; Skakodub, A.; Ahmad, H.; Yu, H. A.; more...
Journal of Molecular Diagnostics (2021)

Fulltext@MSK | Save